Charles Schwab Investment Management Inc Silk Road Medical Inc Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Silk Road Medical Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 308,467 shares of SILK stock, worth $8.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,467

Previous 281,217 9.69%

Holding current value

$8.34 Million

Previous $3.45 Million 63.8%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$11.38 - $19.03 $310,105 - $518,567	27,250 Added 9.69%	308,467 $5.65 Million
Q4 2023 Feb 06, 2024	SELL	$6.29 - $15.72 $106,470 - $266,092	-16,927 Reduced 5.68%	281,217 $3.45 Million
Q3 2023 Nov 08, 2023	BUY	$14.99 - $32.65 $144,908 - $315,627	9,667 Added 3.35%	298,144 $4.47 Million
Q2 2023 Aug 09, 2023	BUY	$29.76 - $46.14 $182,875 - $283,530	6,145 Added 2.18%	288,477 $9.37 Million
Q1 2023 May 11, 2023	BUY	$38.09 - $57.79 $30,586 - $46,405	803 Added 0.29%	282,332 $11 Million

Q4 2022 Feb 13, 2023	BUY	$40.54 - $56.2 $1.12 Million - $1.55 Million	27,629 Added 10.88%	281,529 $14.9 Million
Q3 2022 Nov 14, 2022	BUY	$36.98 - $49.2 $215,667 - $286,934	5,832 Added 2.35%	253,900 $11.4 Million
Q2 2022 Aug 15, 2022	SELL	$28.03 - $45.8 $137,066 - $223,962	-4,890 Reduced 1.93%	248,068 $9.03 Million
Q1 2022 May 13, 2022	BUY	$29.24 - $44.06 $253,159 - $381,471	8,658 Added 3.54%	252,958 $10.4 Million
Q4 2021 Feb 11, 2022	BUY	$39.32 - $61.61 $182,405 - $285,808	4,639 Added 1.94%	244,300 $10.4 Million
Q3 2021 Nov 16, 2021	BUY	$44.0 - $65.8 $139,964 - $209,309	3,181 Added 1.35%	239,661 $13.2 Million
Q2 2021 Aug 16, 2021	BUY	$44.66 - $63.06 $788,695 - $1.11 Million	17,660 Added 8.07%	236,480 $11.3 Million
Q1 2021 May 17, 2021	BUY	$46.31 - $62.7 $353,345 - $478,401	7,630 Added 3.61%	218,820 $11.1 Million
Q4 2020 Feb 16, 2021	BUY	$55.51 - $69.94 $287,874 - $362,708	5,186 Added 2.52%	211,190 $13.3 Million
Q3 2020 Nov 13, 2020	BUY	$42.19 - $69.61 $3.32 Million - $5.47 Million	78,637 Added 61.74%	206,004 $13.8 Million
Q2 2020 Aug 14, 2020	BUY	$27.55 - $43.28 $1.83 Million - $2.87 Million	66,281 Added 108.5%	127,367 $5.34 Million
Q1 2020 May 15, 2020	BUY	$23.16 - $47.8 $22,812 - $47,083	985 Added 1.64%	61,086 $1.92 Million
Q4 2019 Feb 07, 2020	BUY	$27.97 - $40.38 $279,867 - $404,042	10,006 Added 19.97%	60,101 $2.43 Million
Q3 2019 Nov 08, 2019	BUY	$31.65 - $46.94 $374,957 - $556,098	11,847 Added 30.97%	50,095 $1.63 Million
Q2 2019 Aug 09, 2019	BUY	$32.5 - $49.12 $1.24 Million - $1.88 Million	38,248 New	38,248 $1.85 Million

Others Institutions Holding SILK

# of Institutions

157

Shares Held

41.8M

Call Options Held

428K

Put Options Held

199K

View Full List

About Silk Road Medical Inc

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.02B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

More about SILK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Silk Road Medical Inc Transaction History